Atlas Trials

Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

Clinical trial NCT02621047 · COMPLETED

Trial details

NCT number
NCT02621047
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2015-12-04
Primary completion
2016-12-08
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.